Candel Therapeutics, Inc.CADLNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank100
3Y CAGR+7.5%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+7.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$2.12M+1.4%
2024$2.09M+306.6%
2023$514000.00-69.9%
2022$1.71M+3122.6%
2021$53000.00-
2020$0.00-
2019$0.00-